Old Web
English
Sign In
Acemap
>
authorDetail
>
Hyon-Zu Lee
Hyon-Zu Lee
Center for Drug Evaluation and Research
Immunology
Medicine
Untreated Chronic Lymphocytic Leukemia
Drug
Obinutuzumab
2
Papers
223
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
2015
Clinical Cancer Research
Hyon-Zu Lee
Virginia E. Kwitkowski
Pedro L. Del Valle
M. Stacey Ricci
Haleh Saber
Bahru A. Habtemariam
Julie Bullock
Erik Bloomquist
Yuan Li Shen
Xiao Hong Chen
Janice Brown
Nitin Mehrotra
Sarah E. Dorff
Rosane Charlab
Robert C. Kane
Edvardas Kaminskas
Robert Justice
Ann T. Farrell
Richard Pazdur
Show All
Source
Cite
Save
Citations (191)
U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
2014
Clinical Cancer Research
Hyon-Zu Lee
Barry R. Miller
Virginia E. Kwitkowski
Stacey Ricci
Pedro Delvalle
Haleh Saber
Joseph A. Grillo
Julie Bullock
Jeffry Florian
Nitin Mehrotra
Chia-wen Ko
Lei Nie
Marjorie A. Shapiro
Mate Tolnay
Robert C. Kane
Edvardas Kaminskas
Robert Justice
Ann T. Farrell
Richard Pazdur
Show All
Source
Cite
Save
Citations (32)
1